BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36738468)

  • 21. Wound healing complications after revascularization for moyamoya vasculopathy with reference to different skin incisions.
    Acker G; Schlinkmann N; Fekonja L; Grünwald L; Hardt J; Czabanka M; Vajkoczy P
    Neurosurg Focus; 2019 Feb; 46(2):E12. PubMed ID: 30717062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.
    Scala M; Fiaschi P; Capra V; Garrè ML; Tortora D; Ravegnani M; Pavanello M
    Childs Nerv Syst; 2018 Jul; 34(7):1311-1323. PubMed ID: 29797062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.
    Li Z; Lu J; Ma L; Wu C; Xu Z; Chen X; Ye X; Wang R; Zhao Y
    J Neurosurg; 2019 Feb; 132(2):421-433. PubMed ID: 30771781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case series.
    Morello A; Scala M; Schiavetti I; Diana MC; Severino M; Tortora D; Piatelli G; Pavanello M
    Childs Nerv Syst; 2024 Jun; 40(6):1731-1741. PubMed ID: 38316674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pediatric moyamoya MRI score: an imaging-based scale to predict outcomes in surgically treated pediatric patients with moyamoya.
    Garcia JH; Morshed RA; Winkler EA; Li Y; Fox CK; Fullerton HJ; Rutledge C; Beniwal AS; Lawton MT; Abla AA; Gupta N; Hetts SW
    Neurosurg Focus; 2021 Sep; 51(3):E8. PubMed ID: 34469869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes after revascularization for pediatric moyamoya disease and syndrome: A single-center series.
    Morshed RA; Abla AA; Murph D; Dao JM; Winkler EA; Burkhardt JK; Colao K; Hetts SW; Fullerton HJ; Lawton MT; Gupta N; Fox CK
    J Clin Neurosci; 2020 Sep; 79():137-143. PubMed ID: 33070883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation-Induced Moyamoya Syndrome after Proton Beam Therapy in the Pediatric Patient: A Case Series.
    Reynolds MR; Haydon DH; Caird J; Leonard JR
    Pediatr Neurosurg; 2016; 51(6):297-301. PubMed ID: 27193755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moyamoya syndrome as a risk factor for stroke in Saudi children. Novel and usual associations.
    Salih MA; Murshid WR; Al-Salman MM; Abdel-Gader AG; Al-Jarallah AA; Alorainy IA; Hassan HH; Kentab AY; Van Maldergem L; Othman SA; El-Desouki MI; Elgamal EA
    Saudi Med J; 2006 Mar; 27 Suppl 1():S69-80. PubMed ID: 16532134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The incidence of radiation-induced moyamoya among pediatric brain tumor patients who received photon radiation versus those who received proton beam therapy: a systematic review.
    Elkatatny A; Ismail M; Ibrahim KMM; Aly MH; Fouda MA
    Neurosurg Rev; 2023 Jun; 46(1):146. PubMed ID: 37354243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term Outcome After Multiple Burr Hole Surgery in Children With Moyamoya Angiopathy: A Single-Center Experience in 108 Hemispheres.
    Blauwblomme T; Mathon B; Naggara O; Kossorotoff M; Bourgeois M; Puget S; Meyer P; Brousse V; de Montalembert M; Brunelle F; Zerah M; Sainte-Rose C
    Neurosurgery; 2017 Jun; 80(6):950-956. PubMed ID: 28327981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton Radiation Therapy for Pediatric Craniopharyngioma.
    Jimenez RB; Ahmed S; Johnson A; Thomas H; Depauw N; Horick N; Tansky J; Evans CL; Pulsifer M; Ebb D; Butler WE; Fullerton B; Tarbell NJ; Yock TI; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1480-1487. PubMed ID: 33662460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical outcomes for moyamoya angiopathy at barrow neurological institute with comparison of adult indirect encephaloduroarteriosynangiosis bypass, adult direct superficial temporal artery-to-middle cerebral artery bypass, and pediatric bypass: 154 revascularization surgeries in 140 affected hemispheres.
    Abla AA; Gandhoke G; Clark JC; Oppenlander ME; Velat GJ; Zabramski JM; Albuquerque FC; Nakaji P; Spetzler RF; Wanebo JE
    Neurosurgery; 2013 Sep; 73(3):430-9. PubMed ID: 23756739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience of treatment of moyamoya disease at the Clinic of Neurosurgery of Kaunas University of Medicine.
    Marcinkevicius E; Liutkus D; Gvazdaitis A
    Medicina (Kaunas); 2006; 42(2):130-6. PubMed ID: 16528129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct versus indirect bypass procedure for the treatment of ischemic moyamoya disease: results of an individualized selection strategy.
    Nielsen TH; Abhinav K; Sussman ES; Han SS; Weng Y; Bell-Stephens T; ; Heit JJ; Steinberg GK
    J Neurosurg; 2020 Jun; 134(5):1578-1589. PubMed ID: 32534489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.